MULTIMERIC SOLUBLE FAS LIGAND FOR ELIMINATING ALLOREACTIVE T LYMPHOCYTE IN ALLOGENIC HARMATOPOIETIC STEM-CELL TRANSPLANTATION TRANSPLANTATION

摘要

The present invention concerns novel approaches for eliminating activated allo-reactive T lymphocyte in vivo and in vitro, preventing GVHD development with a sufficient amount of a multimeric form of the soluble portion of FasL as defined below.